Market Access/ News/ News FDA approves generic under new strategy to boost competition Piotr Wnuk biogenerics, FDA approval, generics, hypokalemia, market access 0 Comment The US regulator has approved a drug to treat low potassium as the first generic with the Competitive Share X FDA approves generic under new strategy to boost competition https://pharmaphorum.com/news/fda-approved-hypokalymia-generic-cgt/
biogenerics, FDA approval, generics, hypokalemia, market access
0 Comment
